Evolution of bone mineral density in AIDS patients on treatment with zidovudine/lamivudine plus abacavir or lopinavir/ritonavir

P. Rivas(Hospital Clínico San Carlos), ML Fernández‐Guerrero(Hospital Universitario Fundación Jiménez Díaz), Díaz Curiel M(Hospital Universitario Fundación Jiménez Díaz), A. Goyenechea, Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), R. García-Delgado(Hospital Universitario Fundación Jiménez Díaz)
HIV Medicine
December 18, 2007
10.1111/j.1468-1293.2007.00525.x
Cited by 55

Related Papers

Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain
|PLoS ONE|2018|179
Severe Dengue Virus Infection in Travelers: Risk Factors and Laboratory Indicators
|The Journal of Infectious Diseases|2007|173
Hospital-Acquired Infectious Endocarditis Not Associated with Cardiac Surgery: An Emerging Problem
|Clinical Infectious Diseases|1995|170
The Spectrum of Cardiovascular Infections due to Salmonella enterica
|Medicine|2004|155
Initial Use of Echinocandins Does Not Negatively Influence Outcome in Candida parapsilosis Bloodstream Infection: A Propensity Score Analysis
|Clinical Infectious Diseases|2014|124